Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$265.90
Buy
$266.30
$-6.19 (-2.28%)
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Prices updated at 10 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$273.48 - $265.66 | |
$346.85 - $253.30 | |
3.14 | |
142,954.55m | |
24.24 | |
- | |
3,328,886 | |
23.03 | |
2,721,995.34 | |
0.56 | |
537.00m | |
US0311621009 | |
10.97 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.